We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

On October 30, 2024, Carina Biotech, a clinical-stage immuno-oncology company developing CAR-T and other cell therapies for the treatment of solid cancers, made a milestone payment of AUS$1M to ...

Merck, Pfizer, Jazz, Takeda, Gilead Sciences, and Baxter International. For more information, please visit www.ligand.com. Follow Ligand on X @Ligand_LGND. We use our investor relations website and X ...

Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced ...

Welcome to the Merck & Company Q3 sales and earnings conference call. [Operator instructions] This call is being recorded.

Merck's third-quarter financial performance in 2024 showcased robust worldwide sales growth of 4%, reaching $16.7 billion.

Merck, a leading science and technology company, today announced a € 70 million expansion of its ADC manufacturing capabilities and capacity at its Bioconjugation Center of Excellence facility ...

Commissions do not affect our editors' opinions or evaluations. Thanks to website builders, it’s easier than ever to create your own website without having any coding knowledge. Website builders ...

The Merck Foundation is dedicated to improving social and health ... Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible ...